Reversal of subcellular remodelling by losartan in heart failure due to myocardial infarction

This study tested the reversal of subcellular remodelling in heart failure due to myocardial infarction (MI) upon treatment with losartan, an angiotensin II receptor antagonist. Twelve weeks after inducing MI, rats were treated with or without losartan (20 mg/kg; daily) for 8 weeks and assessed for...

Descripción completa

Detalles Bibliográficos
Autores principales: Babick, Andrea, Chapman, Donald, Zieroth, Shelley, Elimban, Vijayan, Dhalla, Naranjan S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393724/
https://www.ncbi.nlm.nih.gov/pubmed/22947202
http://dx.doi.org/10.1111/j.1582-4934.2012.01623.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393724/
https://www.ncbi.nlm.nih.gov/pubmed/22947202
http://dx.doi.org/10.1111/j.1582-4934.2012.01623.x

Ejemplares similares